Invention Grant
- Patent Title: Neuroendocrine tumors
-
Application No.: US15656998Application Date: 2017-07-21
-
Publication No.: US11549148B2Publication Date: 2023-01-10
- Inventor: Catherine A. Schnabel , Yi Zhang , Mark G. Erlander
- Applicant: BIOTHERANOSTICS, INC.
- Applicant Address: US CA San Diego
- Assignee: BIOTHERANOSTICS, INC.
- Current Assignee: BIOTHERANOSTICS, INC.
- Current Assignee Address: US CA San Diego
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Agent Michael J. Gilly
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886
Abstract:
The disclosure provides methods for the use of gene expression measurements to classify or identify neuroendocrine cancer in samples obtained from a subject in a clinical setting, such as in cases of formalin fixed, paraffin embedded (FFPE) samples.
Public/Granted literature
- US20180135131A1 NEUROENDOCRINE TUMORS Public/Granted day:2018-05-17
Information query
IPC分类:
